Similar data (reduction of the risk of ER-positive BC and an increase in the risk of ER-negative BC with an increase in SHBG levels) were obtained in the study of Chen et al., performed on the basis of the MR of Breast Cancer Association Consortium data [14]. The gene discussed is SHBG; the disease is breast cancer.